Mechanistically, circ-MYLK binds to miR-513a-5p, avoiding the deleterious role of miR-513a-5p in VEGF-C expression levels, thereby promoting the tumorigenesis of RCC cells (Li et al., 2020b). Here, MYLK is linked to renal cell carcinoma.